Akoya Biosciences, Inc. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported revenue was USD 25.22 million compared to USD 18.85 million a year ago. Net loss was USD 12.92 million compared to USD 17.87 million a year ago. Basic loss per share from continuing operations was USD 0.26 compared to USD 0.47 a year ago.
For the nine months, revenue was USD 70.15 million compared to USD 53.64 million a year ago. Net loss was USD 52.52 million compared to USD 51.77 million a year ago. Basic loss per share from continuing operations was USD 1.23 compared to USD 1.37 a year ago.